 | • レポートコード：QYR9ST03597 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がん遺伝子治療の世界市場について調査・分析し、がん遺伝子治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（腫瘍溶解性ウイルス療法、遺伝子導入、遺伝子誘導免疫療法）、用途別（病院、診断センター、研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがん遺伝子治療市場動向 ・主要企業別マーケットシェア ・がん遺伝子治療の種類別市場規模2014-2019 （腫瘍溶解性ウイルス療法、遺伝子導入、遺伝子誘導免疫療法） ・がん遺伝子治療の用途別市場規模2014-2019 （病院、診断センター、研究機関） ・がん遺伝子治療の北米市場：主要企業・種類別/用途別市場規模 ・がん遺伝子治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がん遺伝子治療の中国市場：主要企業・種類別/用途別市場規模 ・がん遺伝子治療の日本国内市場：主要企業・種類別/用途別市場規模 ・がん遺伝子治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・がん遺伝子治療のインド市場：主要企業・種類別/用途別市場規模 ・がん遺伝子治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Adaptimmune、Bluebird bio、Celgene、Shanghai Sunway Biotech、Shenzhen SiBiono GeneTech、SynerGene Therapeutics、Altor BioScience、Amgen、Argenx、BioCancell、GlaxoSmithKline、Merck、OncoGenex Pharmaceuticals、Transgene） ・がん遺伝子治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.Several unmet medical needs for treatment of cancer have encouraged R&D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.
Americas will the major revenue contributor to this market due to the huge investment in the R&D activities for the healthcare segment to curb the rising number of cancer-related deaths in the region. The region’s focus on R&D has resulted in the emergence of several new treatment options that have long-term effect with minimum side effects.
In 2018, the global Cancer Gene Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cancer Gene Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Gene Therapy development in United States, Europe and China.
The key players covered in this study
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market segment by Type, the product can be split into
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Market segment by Application, split into
Hospitals
Diagnostics Centers
Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Gene Therapy status, future forecast, growth opportunity, key market and key players.
To present the Cancer Gene Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Gene Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Gene Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Oncolytic Virotherapy
1.4.3 Gene Transfer
1.4.4 Gene-Induced Immunotherapy
1.5 Market by Application
1.5.1 Global Cancer Gene Therapy Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Gene Therapy Market Size
2.2 Cancer Gene Therapy Growth Trends by Regions
2.2.1 Cancer Gene Therapy Market Size by Regions (2014-2025)
2.2.2 Cancer Gene Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Gene Therapy Market Size by Manufacturers
3.1.1 Global Cancer Gene Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Gene Therapy Key Players Head office and Area Served
3.3 Key Players Cancer Gene Therapy Product/Solution/Service
3.4 Date of Enter into Cancer Gene Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Gene Therapy Market Size by Type (2014-2019)
4.2 Global Cancer Gene Therapy Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Gene Therapy Market Size (2014-2019)
5.2 Cancer Gene Therapy Key Players in United States
5.3 United States Cancer Gene Therapy Market Size by Type
5.4 United States Cancer Gene Therapy Market Size by Application
6 Europe
6.1 Europe Cancer Gene Therapy Market Size (2014-2019)
6.2 Cancer Gene Therapy Key Players in Europe
6.3 Europe Cancer Gene Therapy Market Size by Type
6.4 Europe Cancer Gene Therapy Market Size by Application
7 China
7.1 China Cancer Gene Therapy Market Size (2014-2019)
7.2 Cancer Gene Therapy Key Players in China
7.3 China Cancer Gene Therapy Market Size by Type
7.4 China Cancer Gene Therapy Market Size by Application
8 Japan
8.1 Japan Cancer Gene Therapy Market Size (2014-2019)
8.2 Cancer Gene Therapy Key Players in Japan
8.3 Japan Cancer Gene Therapy Market Size by Type
8.4 Japan Cancer Gene Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Gene Therapy Market Size (2014-2019)
9.2 Cancer Gene Therapy Key Players in Southeast Asia
9.3 Southeast Asia Cancer Gene Therapy Market Size by Type
9.4 Southeast Asia Cancer Gene Therapy Market Size by Application
10 India
10.1 India Cancer Gene Therapy Market Size (2014-2019)
10.2 Cancer Gene Therapy Key Players in India
10.3 India Cancer Gene Therapy Market Size by Type
10.4 India Cancer Gene Therapy Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Gene Therapy Market Size (2014-2019)
11.2 Cancer Gene Therapy Key Players in Central & South America
11.3 Central & South America Cancer Gene Therapy Market Size by Type
11.4 Central & South America Cancer Gene Therapy Market Size by Application
12 International Players Profiles
12.1 Adaptimmune
12.1.1 Adaptimmune Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Gene Therapy Introduction
12.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2014-2019)
12.1.5 Adaptimmune Recent Development
12.2 Bluebird bio
12.2.1 Bluebird bio Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Gene Therapy Introduction
12.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2014-2019)
12.2.5 Bluebird bio Recent Development
12.3 Celgene
12.3.1 Celgene Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Gene Therapy Introduction
12.3.4 Celgene Revenue in Cancer Gene Therapy Business (2014-2019)
12.3.5 Celgene Recent Development
12.4 Shanghai Sunway Biotech
12.4.1 Shanghai Sunway Biotech Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Gene Therapy Introduction
12.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2014-2019)
12.4.5 Shanghai Sunway Biotech Recent Development
12.5 Shenzhen SiBiono GeneTech
12.5.1 Shenzhen SiBiono GeneTech Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Gene Therapy Introduction
12.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2014-2019)
12.5.5 Shenzhen SiBiono GeneTech Recent Development
12.6 SynerGene Therapeutics
12.6.1 SynerGene Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Gene Therapy Introduction
12.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2014-2019)
12.6.5 SynerGene Therapeutics Recent Development
12.7 Altor BioScience
12.7.1 Altor BioScience Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Gene Therapy Introduction
12.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2014-2019)
12.7.5 Altor BioScience Recent Development
12.8 Amgen
12.8.1 Amgen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Gene Therapy Introduction
12.8.4 Amgen Revenue in Cancer Gene Therapy Business (2014-2019)
12.8.5 Amgen Recent Development
12.9 Argenx
12.9.1 Argenx Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Gene Therapy Introduction
12.9.4 Argenx Revenue in Cancer Gene Therapy Business (2014-2019)
12.9.5 Argenx Recent Development
12.10 BioCancell
12.10.1 BioCancell Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Gene Therapy Introduction
12.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2014-2019)
12.10.5 BioCancell Recent Development
12.11 GlaxoSmithKline
12.12 Merck
12.13 OncoGenex Pharmaceuticals
12.14 Transgene
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cancer Gene Therapy Key Market Segments
Table Key Players Cancer Gene Therapy Covered
Table Global Cancer Gene Therapy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cancer Gene Therapy Market Size Market Share by Type 2014-2025
Figure Oncolytic Virotherapy Figures
Table Key Players of Oncolytic Virotherapy
Figure Gene Transfer Figures
Table Key Players of Gene Transfer
Figure Gene-Induced Immunotherapy Figures
Table Key Players of Gene-Induced Immunotherapy
Table Global Cancer Gene Therapy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Diagnostics Centers Case Studies
Figure Research Institutes Case Studies
Figure Cancer Gene Therapy Report Years Considered
Table Global Cancer Gene Therapy Market Size 2014-2025 (Million US$)
Figure Global Cancer Gene Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Gene Therapy Market Size by Regions 2014-2025 (Million US$)
Table Global Cancer Gene Therapy Market Size by Regions 2014-2019 (Million US$)
Table Global Cancer Gene Therapy Market Share by Regions 2014-2019
Figure Global Cancer Gene Therapy Market Share by Regions 2014-2019
Figure Global Cancer Gene Therapy Market Share by Regions 2019
Table Market Top Trends
Table Global Cancer Gene Therapy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cancer Gene Therapy Market Share by Manufacturers (2014-2019)
Figure Global Cancer Gene Therapy Market Share by Manufacturers in 2018
Table Global Cancer Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Gene Therapy Product/Solution/Service
Table Date of Enter into Cancer Gene Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Gene Therapy Market Size Share by Type (2014-2019)
Figure Global Cancer Gene Therapy Market Size Market Share by Type (2014-2019)
Table Global Cancer Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Gene Therapy Market Size Share by Application (2014-2019)
Figure Global Cancer Gene Therapy Market Size Market Share by Application (2014-2019)
Figure Global Cancer Gene Therapy Revenue Market Share by Application in 2018
Figure United States Cancer Gene Therapy Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Gene Therapy Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Gene Therapy Market Share (2018-2019)
Table United States Cancer Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Gene Therapy Market Share by Type (2014-2019)
Table United States Cancer Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Gene Therapy Market Share by Application (2014-2019)
Figure Europe Cancer Gene Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Gene Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Gene Therapy Market Share (2018-2019)
Table Europe Cancer Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Gene Therapy Market Share by Type (2014-2019)
Table Europe Cancer Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Gene Therapy Market Share by Application (2014-2019)
Figure China Cancer Gene Therapy Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Gene Therapy Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Gene Therapy Market Share (2018-2019)
Table China Cancer Gene Therapy Market Size by Type (2014-20189) (Million US$)
Table China Cancer Gene Therapy Market Share by Type (2014-2019)
Table China Cancer Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table China Cancer Gene Therapy Market Share by Application (2014-2019)
Figure Japan Cancer Gene Therapy Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Gene Therapy Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Gene Therapy Market Share (2018-2019)
Table Japan Cancer Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Gene Therapy Market Share by Type (2014-2019)
Table Japan Cancer Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Gene Therapy Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Gene Therapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Gene Therapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Gene Therapy Market Share (2018-2019)
Table Southeast Asia Cancer Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Gene Therapy Market Share by Type (2014-2019)
Table Southeast Asia Cancer Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Gene Therapy Market Share by Application (2014-2019)
Figure India Cancer Gene Therapy Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Gene Therapy Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Gene Therapy Market Share (2018-2019)
Table India Cancer Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table India Cancer Gene Therapy Market Share by Type (2014-2019)
Table India Cancer Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table India Cancer Gene Therapy Market Share by Application (2014-2019)
Figure Central & South America Cancer Gene Therapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Gene Therapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Gene Therapy Market Share (2018-2019)
Table Central & South America Cancer Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Gene Therapy Market Share by Type (2014-2019)
Table Central & South America Cancer Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Gene Therapy Market Share by Application (2014-2019)
Table Adaptimmune Company Details
Table Adaptimmune Revenue in Cancer Gene Therapy Business (2014-2019) (Million US$)
Figure Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table Adaptimmune Recent Development
Table Bluebird bio Company Details
Table Bluebird bio Revenue in Cancer Gene Therapy Business (2014-2019)(Million US$)
Figure Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table Bluebird bio Recent Development
Table Celgene Company Details
Table Celgene Revenue in Cancer Gene Therapy Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table Celgene Recent Development
Table Shanghai Sunway Biotech Company Details
Table Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2014-2019)(Million US$)
Figure Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table Shanghai Sunway Biotech Recent Development
Table Shenzhen SiBiono GeneTech Company Details
Table Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2014-2019)(Million US$)
Figure Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table Shenzhen SiBiono GeneTech Recent Development
Table SynerGene Therapeutics Company Details
Table SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2014-2019)(Million US$)
Figure SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table SynerGene Therapeutics Recent Development
Table Altor BioScience Company Details
Table Altor BioScience Revenue in Cancer Gene Therapy Business (2014-2019)(Million US$)
Figure Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table Altor BioScience Recent Development
Table Amgen Company Details
Table Amgen Revenue in Cancer Gene Therapy Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table Amgen Recent Development
Table Argenx Company Details
Table Argenx Revenue in Cancer Gene Therapy Business (2014-2019)(Million US$)
Figure Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table Argenx Recent Development
Table BioCancell Company Details
Table BioCancell Revenue in Cancer Gene Therapy Business (2014-2019)(Million US$)
Figure BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2014-2019)
Table BioCancell Recent Development
Table GlaxoSmithKline Company Details
Table Merck Company Details
Table OncoGenex Pharmaceuticals Company Details
Table Transgene Company Details
Table Global Cancer Gene Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Gene Therapy Market Size Share by Regions (2019-2025)
Figure Global Cancer Gene Therapy Market Size Share by Regions in 2025
Figure United States Cancer Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Gene Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Gene Therapy Market Size by Product (2019-2025)
Figure Global Cancer Gene Therapy Market Size by Product in 2025
Table Global Cancer Gene Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Gene Therapy Market Size by Application (2019-2025)
Figure Global Cancer Gene Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
卵巣癌遺伝子治療の世界市場：市場規模・現状・予測 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- ムコ多糖症遺伝子治療の世界市場：市場規模・現状・予測 Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …
- 加齢黄斑変性症遺伝子治療の世界市場：市場規模・現状・予測 Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 世界の腫瘍治療用遺伝子治療市場：専門的調査 Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…
- DNA遺伝子チップの世界市場：市場規模・現状・予測 DNA gene chips or DNA microarrays are tiny chips that are engrafted with DNA molecules. A DNA gene chip size resembles the size of a postage stamp. A DNA microarray consists of a set of microscopic DNA spots attached on a solid surface. Every DNA spot consists of picomoles of a definite DNA sequence…